IL113879A - Antiviral compositions for administration via oral inhalation or insufflation, their preparation and method of such treatment - Google Patents

Antiviral compositions for administration via oral inhalation or insufflation, their preparation and method of such treatment

Info

Publication number
IL113879A
IL113879A IL11387995A IL11387995A IL113879A IL 113879 A IL113879 A IL 113879A IL 11387995 A IL11387995 A IL 11387995A IL 11387995 A IL11387995 A IL 11387995A IL 113879 A IL113879 A IL 113879A
Authority
IL
Israel
Prior art keywords
administration
insufflation
inhalation
glycero
guanidino
Prior art date
Application number
IL11387995A
Other languages
English (en)
Other versions
IL113879A0 (en
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management filed Critical Biota Scient Management
Publication of IL113879A0 publication Critical patent/IL113879A0/xx
Publication of IL113879A publication Critical patent/IL113879A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
IL11387995A 1994-05-28 1995-05-26 Antiviral compositions for administration via oral inhalation or insufflation, their preparation and method of such treatment IL113879A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9410817A GB9410817D0 (en) 1994-05-28 1994-05-28 Medicaments

Publications (2)

Publication Number Publication Date
IL113879A0 IL113879A0 (en) 1995-08-31
IL113879A true IL113879A (en) 2001-01-11

Family

ID=10755922

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11387995A IL113879A (en) 1994-05-28 1995-05-26 Antiviral compositions for administration via oral inhalation or insufflation, their preparation and method of such treatment

Country Status (12)

Country Link
EP (1) EP0764023B1 (ja)
JP (1) JPH10500966A (ja)
AT (1) ATE221778T1 (ja)
AU (1) AU701590B2 (ja)
DE (1) DE69527713T2 (ja)
DK (1) DK0764023T3 (ja)
ES (1) ES2176330T3 (ja)
GB (1) GB9410817D0 (ja)
IL (1) IL113879A (ja)
PT (1) PT764023E (ja)
WO (1) WO1995032712A1 (ja)
ZA (1) ZA954331B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE305453T1 (de) * 1995-02-27 2005-10-15 Gilead Sciences Inc Selektive inhibitoren viraler oder bakterieller neuraminidase
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
BR9714299A (pt) 1996-11-14 2000-04-25 Biota Scient Mangent Pty Ltd Composto macromolecular, processos para detecção de virus da influenza e tratamento de infeção da influenza, composição farmacêutica para esse tratamento e utilização de composto
AU5546898A (en) * 1997-01-14 1998-08-07 Hopital Sainte-Justine Human lysosomal sialidase and therapeutic uses thereof
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
TW480247B (en) * 1997-12-12 2002-03-21 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
MX2013003523A (es) * 2010-09-27 2013-05-22 Cipla Ltd Composicion farmaceutica de dosis baja.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01287029A (ja) * 1988-05-13 1989-11-17 Mect Corp 新規抗ウィルス剤
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid

Also Published As

Publication number Publication date
GB9410817D0 (en) 1994-07-20
AU701590B2 (en) 1999-02-04
ZA954331B (en) 1996-01-29
PT764023E (pt) 2002-12-31
IL113879A0 (en) 1995-08-31
ATE221778T1 (de) 2002-08-15
AU2615795A (en) 1995-12-21
WO1995032712A1 (en) 1995-12-07
DE69527713T2 (de) 2003-04-10
DE69527713D1 (de) 2002-09-12
EP0764023B1 (en) 2002-08-07
ES2176330T3 (es) 2002-12-01
EP0764023A1 (en) 1997-03-26
DK0764023T3 (da) 2002-11-18
JPH10500966A (ja) 1998-01-27

Similar Documents

Publication Publication Date Title
KR100910888B1 (ko) 에어로졸화 이송을 위한 적절한 토브라마이싱의 조성물
RU2001123923A (ru) Композиции, включающие формотерол и соль тиотропия
AU701590B2 (en) Compounds and compositions for administration via oral inhalation or insufflation
AU2002319226A1 (en) Optimised formulation of tobramycin for aerosolization
WO2001051030A1 (en) Pharmaceutical formulation and method for pulmonary and oral delivery
EA022840B1 (ru) Фармацевтическая композиция, набор, их применение и способ профилактики и лечения симптома, состояния или заболевания, связанного с инфекцией вируса гриппа
US6747058B1 (en) Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
EP3474842A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
KR101312331B1 (ko) 약학적 코 제형물 및 이의 이용 방법
CN112912074A (zh) Egcg-棕榈酸酯组合物及其使用方法
EP1212039A1 (en) Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
GB2162745A (en) Nasal compositions
US11090315B1 (en) Prevention and treatment of flu-type viral infections and related complications
IE66819B1 (en) Composition for the prophylaxis or treatment of pneumocystis carinii pneumonia
CN113350323A (zh) 一种用于抑制冠状病毒的吸入剂及其制备方法和应用
US20230201309A1 (en) Compositions for the treatment of a respiratory condition
KR20230005937A (ko) 바이러스 감염의 치료 또는 예방을 위한 클로파지민 조성물 및 방법
EP3906934A1 (en) Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections
US20230145555A1 (en) Composition comprising resveratrol
US4010269A (en) Antiviral quinazoline compositions and methods of use
Debs et al. Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus
US20240165191A1 (en) Compositions and methods for reducing the transmissivity of illnesses using an oral delivery system
TR2023001692T2 (tr) Anti̇vi̇ral, anti̇malaryal ve/veya mukoli̇ti̇k özelli̇kli̇ etki̇n maddeleri̇n yumuşak buğu i̇nhaler veya ti̇treşi̇mli̇ elek teknoloji̇si̇ nebuli̇zer vasitasiyla i̇nhale yolla covid-19 dahi̇l vi̇ral akci̇ğer hastaliklarinin tedavi̇si̇nde kullanimi

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired